Evidence map›Paper›PMID 34359932›Full record

ArticleCells2021

Viral MicroRNAs Encoded by Nucleocapsid Gene of SARS-CoV-2 Are Detected during Infection, and Targeting Metabolic Pathways in Host Cells.

Fei Meng, Gilman Kit-Hang Siu, Bobo Wing-Yee Mok, Jiahong Sun, Kitty S C Fung, Jimmy Yiu-Wing Lam, Nonthaphat Kent Wong, Lealem Gedefaw, Shumeng Luo, Thomas M H Lee and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Fei MengDepartment of Health Technology and Informatics, The Hong Kong Polytechnic University, Kowloon, Hong Kong, China.
Gilman Kit-Hang SiuDepartment of Health Technology and Informatics, The Hong Kong Polytechnic University, Kowloon, Hong Kong, China.
Bobo Wing-Yee MokDepartment of Microbiology, The University of Hong Kong, Hong Kong, China.
Jiahong SunDepartment of Health Technology and Informatics, The Hong Kong Polytechnic University, Kowloon, Hong Kong, China.
Kitty S C FungDepartment of Pathology, United Christian Hospital, Kwun Tong, Hong Kong, China.
Jimmy Yiu-Wing LamDepartment of Clinical Pathology, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong, China.
Nonthaphat Kent WongDepartment of Health Technology and Informatics, The Hong Kong Polytechnic University, Kowloon, Hong Kong, China.
Lealem GedefawDepartment of Health Technology and Informatics, The Hong Kong Polytechnic University, Kowloon, Hong Kong, China.
Shumeng LuoDepartment of Health Technology and Informatics, The Hong Kong Polytechnic University, Kowloon, Hong Kong, China.
Thomas M H LeeDepartment of Biomedical Engineering, The Hong Kong Polytechnic University, Kowloon, Hong Kong, China.ORCID 0000-0003-3950-0232
Shea Ping YipDepartment of Health Technology and Informatics, The Hong Kong Polytechnic University, Kowloon, Hong Kong, China.ORCID 0000-0002-2170-8185
Chien-Ling HuangDepartment of Health Technology and Informatics, The Hong Kong Polytechnic University, Kowloon, Hong Kong, China.ORCID 0000-0002-6396-5649
Hong Kong Polytechnic University · HKPamela Youde Nethersole Eastern Hospital · CNUnited Christian Hospital · CNUniversity of Hong Kong · HK

Funding

Health and Medical Research Fund COVID190208
6 · The paper itself

Abstract

MicroRNAs (miRNAs) are critical regulators of gene expression that may be used to identify the pathological pathways influenced by disease and cellular interactions. Viral miRNAs (v-miRNAs) encoded by both DNA and RNA viruses induce immune dysregulation, virus production, and disease pathogenesis. Given the absence of effective treatment and the prevalence of highly infective SARS-CoV-2 strains, improved understanding of viral-associated miRNAs could provide novel mechanistic insights into the pathogenesis of COVID-19. In this study, SARS-CoV-2 v-miRNAs were identified by deep sequencing in infected Calu-3 and Vero E6 cell lines. Among the ~0.1% small RNA sequences mapped to the SARS-CoV-2 genome, the top ten SARS-CoV-2 v-miRNAs (including three encoded by the

Indexed as

Metabolic Networks and PathwaysAnimalsCell LineChlorocebus aethiopsCoronavirus Nucleocapsid ProteinsCOVID-19Host-Pathogen InteractionsHumansMicroRNAsPhosphoproteinsRNA, ViralSARS-CoV-2Vero CellsCoronavirus Nucleocapsid ProteinsMicroRNAsnucleocapsid phosphoprotein, SARS-CoV-2PhosphoproteinsRNA, Viralcellular metabolismCOVID-19host target genesMicroRNASARS-CoV-2 infection

Identifiers

PMID34359932
PMCPMC8307234
OpenAlexW3181848893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.